|
|
|
|
MOLYBDENUM
Molybdenum
(Mo) is an essential nutrient for animals and humans. Tissue content of
molybdenum is low, with the highest concentrations in the liver, kidney, adrenal
gland and bone. It is a component of a number of enzymes, including sulfite
oxidase (involved in the metabolism of sulfur amino acids), xanthine oxidase
(involved in the oxidation of purines and pyrimidines and the production of uric
acid), and aldehyde oxidase (involved in the oxidation of aldehydes). These
enzymes share a common "molybdenum cofactor."
Deficiencies: Molybdenum deficiency is extremely rare and
has only been identified in the presence of other serious disorders. Metabolic
defects in the molybdenum cofactor are characterized by the absence of the three
molybdoenzymes. Both the deficiency and the metabolic disorders are accompanied
by abnormal excretion of sulfur metabolites, low uric acid concentrations, and
elevated hypoxanthine and xanthine excretion. The absence of sulfite oxidase in
the metabolic disorder leads to death at an early age.
Without sufficient
amounts of Molybdenum to metabolize them, some of these substances may build up
to toxic levels and cause auto-immune disorders.
Diet recommendations: The Estimated Safe and Adequate
Dietary Intakes of molybdenum (µg/day) are: 15-30 at age 0-6 months, 20-40 for
6-12 months, 25-50 for 1-3 years, 30-75 for 4-6 years, 50-150 for 7-10 years,
and 75-250 for adolescents and adults. This range is based on the usual dietary
intake, about 75 to 240 µg/day by adults. The range was extrapolated for other
age groups on the basis of body weight.
Food sources: Rich sources of molybdenum include legumes,
cereal products, and leafy vegetables. The amount in foods depends on the soil
molybdenum content. Molybdenum is very well absorbed, but its bioavailability
may be affected by some food components.
Toxicity: Molybdenum toxicity is much more likely than
deficiency. Toxicity is common in cattle grazing in pastures with high
molybdenum soil. A high incidence of gout has been reported in humans with
intakes of 10-15 mg/day.
Recent research: Controlled studies in humans suggest that
the molybdenum requirement is well below the usual dietary intake, which is
consistent with lack of molybdenum deficiency in the US population.
Bioavailability studies suggest that molybdenum is less well absorbed from soy
products than from leafy vegetables. |
|